What is the current Pathfinder Cell Therapy market capitalization?
The current market capitalization of Pathfinder Cell Therapy is 667.16 USD.
Pathfinder Cell Therapy Market capitalization 2024
Pathfinder Cell Therapy Market capitalization
667.16 USD
Ticker
PFND
ISIN
US70319A1060
WKN
A0EAT6
In 2024, Pathfinder Cell Therapy's market cap stood at 667.16 USD, a 0% increase from the 667.16 USD market cap in the previous year.
The Pathfinder Cell Therapy Market capitalization history
| YEAR | Market Capitalization (undefined USD) |
|---|---|
| 2014 | 0 |
| 2013 | 9.77 |
| 2012 | 20.39 |
| 2011 | 36.58 |
| 2010 | 40.76 |
| 2009 | 21.96 |
| 2008 | 30.24 |
| 2007 | 69.29 |
| 2006 | 67.17 |
| 2005 | 24.92 |
| 2004 | 22.39 |
| 2003 | 13.7 |
| 2002 | 2.97 |
| 2001 | 2.46 |
| 2000 | 3.52 |
| 1999 | 5.35 |
| 1998 | 9.01 |
| 1997 | 33.84 |
| 1996 | 54.03 |
| 1995 | 27.51 |
Pathfinder Cell Therapy Aktienanalyse
What does Pathfinder Cell Therapy do?
Pathfinder Cell Therapy Inc is a biopharmaceutical company specializing in the development of cell-based therapies. The company was founded in 2018 and is headquartered in Boston, Massachusetts. The founders of Pathfinder Cell Therapy have come together to develop innovative solutions for diseases that cannot be treated by conventional therapies. They believe that cell-based therapies have the potential to dramatically improve the lives of patients by directly addressing the underlying causes of their diseases. Pathfinder Cell Therapy's business model focuses on the development of cell-based therapies for specific diseases. The company works closely with academics, scientists, and clinicians to incorporate the latest knowledge and technologies into the development of new therapies. Pathfinder Cell Therapy has various divisions that focus on the development of cell-based therapies for specific diseases. One focus is on developing therapies for rare genetic diseases that are often difficult to treat. Other divisions focus on the development of therapies for cancer and autoimmune diseases. The company already has several products in development, including a cell-based therapy for the treatment of mucopolysaccharidosis type I (MPS-I), a rare genetic disease in which a specific type of sugar cannot be broken down and accumulates in various organs. Pathfinder Cell Therapy also plans to develop cell-based therapies for other rare genetic diseases such as Fabry disease and Krabbe disease. Another important product of Pathfinder Cell Therapy is a cell-based therapy for the treatment of certain types of cancer. This therapy harnesses the ability of immune cells to recognize and attack cancer cells to mobilize the body in the fight against cancer. This type of therapy is called immunotherapy and has made significant advances in recent years. Pathfinder Cell Therapy is also working on the development of cell-based therapies for autoimmune diseases such as rheumatoid arthritis and multiple sclerosis. In these diseases, the immune system mistakenly attacks healthy body cells. Cell-based therapies can help reprogram the immune system to only target pathogens and leave healthy cells unharmed. Overall, Pathfinder Cell Therapy aims to develop the next generation of cell-based therapies to treat diseases that have been difficult or impossible to treat in the past. The company has an experienced team of scientists who work closely with doctors and patients to ensure that their therapies can truly improve people's lives. Pathfinder Cell Therapy is still in the development phase, but the company has already made promising progress and is expected to achieve further success in the coming years. Pathfinder Cell Therapy ist eines der beliebtesten Unternehmen auf Eulerpool.com.Market capitalization Details
Exploring Pathfinder Cell Therapy's Market Capitalization
Pathfinder Cell Therapy's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.
Year-to-Year Comparison
A yearly comparison of Pathfinder Cell Therapy's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.
Impact on Investments
Pathfinder Cell Therapy's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.
Interpreting Market Capitalization Fluctuations
Variations in Pathfinder Cell Therapy’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.
Frequently Asked Questions about Pathfinder Cell Therapy stock
What is market capitalization?
The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like Pathfinder Cell Therapy.
How has the market capitalization of Pathfinder Cell Therapy developed in recent years?
The market capitalization of Pathfinder Cell Therapy has increased/decreased by 0% compared to the previous year.
What does market capitalization mean for investors?
The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.
Why is market capitalization an important indicator for investors?
The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.
Why does the market capitalization fluctuate?
The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.
What role does market capitalization play in the valuation of Pathfinder Cell Therapy?
In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.
Does the market capitalization influence the performance of Pathfinder Cell Therapy?
There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).
Does the market capitalization of Pathfinder Cell Therapy have an influence on indices?
Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).
How much dividend does Pathfinder Cell Therapy pay?
Over the past 12 months, Pathfinder Cell Therapy paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Pathfinder Cell Therapy is expected to pay a dividend of 0 USD.
What is the dividend yield of Pathfinder Cell Therapy?
The current dividend yield of Pathfinder Cell Therapy is .
When does Pathfinder Cell Therapy pay dividends?
Pathfinder Cell Therapy pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Pathfinder Cell Therapy?
Pathfinder Cell Therapy paid dividends every year for the past 0 years.
What is the dividend of Pathfinder Cell Therapy?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Pathfinder Cell Therapy located?
Pathfinder Cell Therapy is assigned to the 'Health' sector.
Wann musste ich die Aktien von Pathfinder Cell Therapy kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Pathfinder Cell Therapy from 11/19/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/19/2024.
When did Pathfinder Cell Therapy pay the last dividend?
The last dividend was paid out on 11/19/2024.
What was the dividend of Pathfinder Cell Therapy in the year 2023?
In the year 2023, Pathfinder Cell Therapy distributed 0 USD as dividends.
In which currency does Pathfinder Cell Therapy pay out the dividend?
The dividends of Pathfinder Cell Therapy are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Pathfinder Cell Therapy
Our stock analysis for Pathfinder Cell Therapy Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Pathfinder Cell Therapy Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- Pathfinder Cell Therapy Revenue
- Pathfinder Cell Therapy Net Income
- Pathfinder Cell Therapy P/E
- Pathfinder Cell Therapy P/S
- Pathfinder Cell Therapy EBIT
- Pathfinder Cell Therapy Dividend
- Pathfinder Cell Therapy Stocks
- Pathfinder Cell Therapy Market capitalization
- Pathfinder Cell Therapy Debt
- Pathfinder Cell Therapy Liabilities
- Pathfinder Cell Therapy Equity
- Pathfinder Cell Therapy AAQS
- Pathfinder Cell Therapy Employees
- Pathfinder Cell Therapy ROE
- Pathfinder Cell Therapy ROA
- Pathfinder Cell Therapy ROCE
